Is the Pharmacological Mode of Action of Chromium(III) as a Second Messenger?

Biological Trace Element Research

Volumn 166, Issue 1, 2015, Pages 7-12

  Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

Chromium; Insulin; Low molecular weight chromium binding substance; Second messenger; Transferrin

Indexed keywords

CHROMIUM; INSULIN RECEPTOR; PROTEIN KINASE B; TRANSFERRIN; CARRIER PROTEIN; CHROMIUM DERIVATIVE; CHROMODULIN PROTEIN, HUMAN; INSULIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOCYTOSIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SECOND MESSENGER; STEADY STATE; TISSUE DISTRIBUTION; ANIMAL; BLOOD; METABOLISM;

RODENTIA;

ANIMALS; CARRIER PROTEINS; CHROMIUM; CHROMIUM COMPOUNDS; HUMANS; INSULIN; RECEPTOR, INSULIN; SECOND MESSENGER SYSTEMS;

EID: 84931006170     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0231-9     Document Type: Article

References (42)

1. Vincent JB (2013) The bioinorganic chemistry of chromium. Wiley, Chichester
2. EFSA Panel on Dietetic Products, Nutrition, and Allergies (2014) Scientific opinion on dietary reference values for chromium. EFSA J 12:3845
3. Vincent JB (2014) Is chromium pharmacologically relevant? J Trace Elem Med Biol 28:397–405
4. 2+/CaM-dependent protein kinase cascade in health and disease. Subcell Biochem 45:169–214
5. Aisen P, Aasa R, Redfield AG (1969) The chromium, manganese, and cobalt complexes of transferrin. J Biol Chem 244:4628–4633
6. Tan AT, Woodworth RC (1969) Ultraviolet difference spectral studies of conalbumin complexes with transition metal ions. Biochemistry 8:3711–3716
7. Harris DC (1977) Different metal-binding properties of the two sites of human transferrin. Biochemistry 16:560–564
8. Ainscough EW, Brodie AM, Plowman JE, Bloor SJ, Sanders Loehr J, Loehr TM (1980) Studies on human lactoferrin by electron paramagnetic resonance, fluorescence, and resonance Raman spectroscopy. Biochemistry 19:4072–4079
9. Ainscough EW, Brodie AM, Plowman JE (1979) The chromium, manganese, cobalt, and copper complexes of human lactoferrin. Inorg Chim Acta 33:149–153
10. Moshtaghie AA, Ani M, Bazrafshan MR (1992) Comparative binding study of aluminum and chromium to human transferrin: effect of iron. Biol Trace Elem Res 32:39–46
11. Ani M, Moshtaghie AA (1992) The effect of chromium on parameters related to iron metabolism. Biol Trace Elem Res 32:57–64
12. Ge D, Wu K, Cruce AA, Bowman MK, Vincent JB (2015) Binding of trivalent chromium to serum transferrin is sufficiently rapid to be physiologically relevant. J Inorg Biochem, in press
13. 3 to LMWCr. J Biol Inorg Chem 5:129–136
14. Vincent JB, Love S (2012) The binding and transport of alterative metals by transferrin. Biochim Biophys Acta 1820:362–378
15. Brock JH (1985) Transferrins. In: Harrison PM (ed) Metalloproteins, 2nd edn. Macmillan, London, pp 183–262
16. Clodfelder BJ, Vincent JB (2005) The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem 10:383–393
17. Clodfelder BJ, Upchurch RG, Vincent JB (2004) A comparison of the insulin-sensitive transport of chromium in healthy and model diabetic rats. J Inorg Biochem 98:522–533
18. Hopkins LL Jr, Schwarz K (1964) Chromium(III) binding to serum proteins, specifically siderophilin. Biochim Biophys Acta 90:484–491
19. Kornfeld S (1969) The effect of metal attachment to human transferrin on its binding to reticulocytes. Biochim Biophys Acta 194:25–33
20. Kandror KV (1999) Insulin regulation of protein traffic in rat adipose cells. J Biol Chem 274:25210–25217
21. 3. J Pharm Dyn 3:17–23
22. Vincent J (2000) The biochemistry of chromium. J Nutr 130:715–718
23. Morris BW, MacNeil S, Stanley K, Gray TA, Fraser R (1993) The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J Endocrinol 139:339–345
24. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KY, Veillon C, Glinsmann W (1982) Urinary chromium excretion of human subjects: effects of chromium supplementation and glucose loading. Am J Clin Nutr 36:1184–1193
25. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KY, Reamer DC (1982) Effect of exercise (running) on serum glucose, insulin, glucagons, and chromium excretion. Diabetes 31:212–216
26. Kozlovsky AS, Moser PB, Reisner S, Anderson RA (1986) Effects of diets high in simple sugars on urinary chromium losses. Metabolism 35:515–518
27. Anderson RA, Bryden NA, Polansky MM, Reiser S (1990) Urinary chromium excretion and insulinogenic properties of carbohydrates. Am J Clin Nutr 51:864–868
28. Morris BM, Blumsohn A, MacNeil S, Gray TA (1992) The trace element chromium—a role in glucose homeostasis. Am J Clin Nutr 55:989–991
29. Morris BM, Griffiths H, Kemp GJ (1988) Effect of glucose loading on concentrations of chromium in plasma and urine of healthy adults. Clin Chem 34:1114–1116
30. Vincent JB (2010) Chromium: celebrating 50 years as an essential element? Dalton Trans 39:3787–3794
31. Vincent JB (2000) Elucidating a biological role for chromium at a molecular level. Acc Chem Res 33:503–510
32. Davis CM, Vincent JB (1997) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36:4382–4385
33. Davis CM, Royer AC, Vincent JB (1997) Synthetic multinuclear chromium assembly activates insulin receptor tyrosine kinase activity: functional model for low-molecular-weight chromium-binding substance. Inorg Chem 36:5316–5320
34. Davis CM, Sumrall KH, Vincent JB (1996) The biologically active form of chromium may activate a membrane phosphotyrosine phopshatase (PTP). Biochemistry 35:12963–12969
35. Goldstein BJ, Zhu L, Hager R, Zilbering A, Sun Y, Vincent JB (2001) Enhancement of post-receptor insulin signaling by trivalent chromium in hepatoma cells is associated with differential inhibition of specific protein-tyrosine phosphatases. J Trace Elem Exp Med 14:393–404
36. Chen Y, Watson HM, Gao J, Halder Sinha S, Cassady CJ, Vincent JB (2011) Characterizing the organic component of low-molecular-weight chromium-binding substance and its binding of chromium. J Nutr 141:1225–1232
37. Yamamoto A, Wada O, Suzuki H (1988) Purification and properties of biologically active chromium complex from bovine colostrum. J Nutr 118:39–45
38. Yamamoto A, Wada O, Manabe S (1989) Evidence that chromium is an essential factor for biological activity of low-molecular-weight Cr-binding substance. Biochem Biophys Res Commun 163:189–193
39. Panzhinskiy E, Ren J, Vincent JB, Sreejayan N (2012) A novel endogenous chromium binding peptide augments glucose uptake and insulin signaling in myotubes. Diabetes 61(1):A412
40. Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS (2006) Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 20:857–870
41. Horvath EM, Tackett L, McCarthy AM, Raman P, Brozinick JT, Elmendorf JS (2008) Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance. Mol Endocrinol 22:937–950
42. Hua Y, Clark S, Ren J, Sreejayan N (2012) Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem 23:313–319